CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity

Molecular Immunology

Volumn 47, Issue 14, 2010, Pages 2303-2313

  Vaitaitis, Gisela M ^a   Wagner, David H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; CD40; Glycosylation; T cells; Th40; TNF receptor

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID RAFT; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRAFFIC AND TRANSPORT;

ANIMALS; ANTIGENS, CD40; AUTOIMMUNITY; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; FEMALE; GLYCOSYLATION; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MOLECULAR WEIGHT; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 77955424415     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.05.288     Document Type: Article

References (44)

1. Baccam M., Bishop G.A. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur. J. Immunol. 1999, 29:3855-3866.
2. Baker R.L., Wagner D.H., Haskins K. CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J. Autoimmun. 2008, 31:385-392.
3. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., Sarvetnick N. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 1997, 159:4620-4627.
4. Bishop G.A., Moore C.R., Xie P., Stunz L.L., Kraus Z.J. TRAF proteins in CD40 signaling. Adv. Exp. Med. Biol. 2007, 597:131-151.
5. Braesch-Andersen S., Paulie S., Koho H., Nika H., Aspenstrom P., Perlmann P. Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40. J. Immunol. 1989, 142:562-567.
6. Brodeur S.R., Angelini F., Bacharier L.B., Blom A.M., Mizoguchi E., Fujiwara H., Plebani A., Notarangelo L.D., Dahlback B., Tsitsikov E., Geha R.S. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 2003, 18:837-848.
7. Datta S.K. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus 1998, 7:591-596.
8. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001, 409:733-739.
9. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., Noelle R.J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993, 261:1328-1330.
10. Fuleihan R., Ramesh N., Geha R.S. Role of CD40-CD40-ligand interaction in Ig-isotype switching. Curr. Opin. Immunol. 1993, 5:963-967.
11. Grigorian A., Lee S.U., Tian W., Chen I.J., Gao G., Mendelsohn R., Dennis J.W., Demetriou M. Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J. Biol. Chem. 2007, 282:20027-20035.
12. Heath A.W., Wu W.W., Howard M.C. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 1994, 24:1828-1834.
13. Jinchuan Y., Zonggui W., Jinming C., Li L., Xiantao K. Upregulation of CD40-CD40 ligand system in patients with diabetes mellitus. Clin. Chim. Acta 2004, 339:85-90.
14. Kobata T., Azuma M., Yagita H., Okumura K. Role of costimulatory molecules in autoimmunity. Rev. Immunogenet. 2000, 2:74-80.
15. Lee S.U., Grigorian A., Pawling J., Chen I.J., Gao G., Mozaffar T., McKerlie C., Demetriou M. N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J. Biol. Chem. 2007, 282:33725-33734.
16. Lutgens E., Daemen M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc. Med. 2002, 12:27-32.
17. Marth J.D., Grewal P.K. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 2008, 8:874-887.
18. Morgan R., Gao G., Pawling J., Dennis J.W., Demetriou M., Li B. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J. Immunol. 2004, 173:7200-7208.
19. Munroe M.E., Bishop G.A. A costimulatory function for T cell CD40. J. Immunol. 2007, 178:671-682.
20. Noelle R.J., Roy M., Shepherd D.M., Stamenkovic I., Ledbetter J.A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6550-6554.
21. Poggi M., Jager J., Paulmyer-Lacroix O., Peiretti F., Gremeaux T., Verdier M., Grino M., Stepanian A., Msika S., Burcelin R., de Prost D., Tanti J.F., Alessi M.C. The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009, 52:1152-1163.
22. Quezada S.A., Eckert M., Adeyi O.A., Schned A.R., Noelle R.J., Burns C.M. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis. Arthritis Rheum. 2003, 48:2541-2554.
23. Rolink A., Melchers F., Andersson J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 1996, 5:319-330.
24. Sprague D.L., Sowa J.M., Elzey B.D., Ratliff T.L. The role of platelet CD154 in the modulation in adaptive immunity. Immunol. Res. 2007, 39:185-193.
25. Suo Z., Wu M., Ameenuddin S., Anderson H.E., Zoloty J.E., Citron B.A., Andrade-Gordon P., Festoff B.W. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 2002, 80:655-666.
26. Tone M., Tone Y., Fairchild P.J., Wykes M., Waldmann H. Regulation of CD40 function by its isoforms generated through alternative splicing. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1751-1756.
27. Toubi E., Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004, 37:457-464.
28. Vaitaitis G.M., Poulin M., Sanderson R.J., Haskins K., Wagner D.H. Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J. Immunol. 2003, 170:3455-3459.
29. Vaitaitis G.M., Wagner D.H. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLoS One 2008, 3:e2076.
30. Vaitaitis, G.M., Waid, D.M., Wagner Jr., D.H., 2010. The expanding role of TNF-receptor super family member CD40 (tnfrsf5) in autoimmune disease: focus on Th40 cells. Curr. Immunol. Rev., in press.
31. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000, 67:2-17.
32. Vogel J.D., West G.A., Danese S., De La Motte C., Phillips M.H., Strong S.A., Willis J., Fiocchi C. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 2004, 126:63-80.
33. Wagner D.H. The co-evolution of our understanding of CD40 and inflammation. Diabetologia 2009, 52:997-999.
34. Wagner D.H., Newell E., Sanderson R.J., Freed J.H., Newell M.K. Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int. J. Mol. Med. 1999, 4:231-242.
35. Wagner D.H., Vaitaitis G., Sanderson R., Poulin M., Dobbs C., Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3782-3787.
36. Waid D.M., Vaitaitis G.M., Pennock N.D., Wagner D.H. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes. J. Leukoc. Biol. 2008, 84:431-439.
37. Waid D.M., Vaitaitis G.M., Wagner D.H. Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur. J. Immunol. 2004, 34:1488-1497.
38. Waid D.M., Wagner R., Putnam A., Vaitaitis G.M., Pennock N.D., Calverley D.C., Gottlieb P., Wagner D.H. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in Human Type 1 Diabetes. Clin. Immunol. 2007, 124:138-148.
39. Wang X., Huang W., Mihara M., Sinha J., Davidson A. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus. J. Immunol. 2002, 168:2046-2053.
40. Wang Y., Kelly C.G., Karttunen J.T., Whittall T., Lehner P.J., Duncan L., MacAry P., Younson J.S., Singh M., Oehlmann W., Cheng G., Bergmeier L., Lehner T. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001, 15:971-983.
41. Wyzgol A., Muller N., Fick A., Munkel S., Grigoleit G.U., Pfizenmaier K., Wajant H. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J. Immunol. 2009, 183:1851-1861.
42. Xie P., Hostager B.S., Munroe M.E., Moore C.R., Bishop G.A. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J. Immunol. 2006, 176:5388-5400.
43. Yang X.D., Tisch R., Singer S.M., Cao Z.A., Liblau R.S., Schreiber R.D., McDevitt H.O. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 1994, 180:995-1004.
44. Yu S., Medling B., Yagita H., Braley-Mullen H. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J. Autoimmun. 2001, 16:37-46.